TP53 and teratoma: A comprehensive study [91] has revealed that WT and mutant p53 ESCs exhibit similar characteristics in doubling time and in vitro differentiation potential, and that despite the difference in p53 status, both ESCs remained pluripotent in vivo and gave rise to benign teratomas upon injection into nude mice.